货号:A1121395
同义名:
Block lipid transport-1
BLT-1是一种特异性SR-BI(清道夫受体B型1)介导的脂质转运抑制剂。该化合物可抑制细胞选择性脂质摄取和细胞胆固醇向HDL的排放。
There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
Type | HazMat fee for 500 gram (Estimated) |
Excepted Quantity | USD 0.00 |
Limited Quantity | USD 15-60 |
Inaccessible (Haz class 6.1), Domestic | USD 80+ |
Inaccessible (Haz class 6.1), International | USD 150+ |
Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | The high-density lipoprotein (HDL) receptor, scavenger receptor, class B, type I (SR-BI), plays an important role in controlling the structure and metabolism of HDL. BLT-1, a thiosemicarbazone copper chelator, is a selective scavenger receptor B, type 1 (SR-BI) inhibitor that inhibits the transfer of lipids between HDL and cells mediated by SR-BI. In ldlA[mSR-BI] cells, BLT-1 had IC50s of 60 and 110 nM for cellular DiI-HDL and [3H]CE-HDL uptake[2]. BLT-1 inhibited SR-BI-dependent selective uptake of [3H]CE from [3H]CE-HDL by mSR-BI-t1-containing liposomes in cells and liposomes with IC50s of 0.057 and 0.098 µM, respectively[3]. |
Concentration | Treated Time | Description | References | |
PCNSL cell lines (HKBML, TK) | 10 µM | 24 hours | Inhibited lymphoma cell proliferation | Cancer Sci. 2022 Jun;113(6):2129-2143. |
COS cells | 1 µM | 1 hour | Assess the effect of BLT-1 on HDL binding and lipid uptake activities of SR-BI mutants (C251S, C384S, C251/384S), showing complete resistance of C384S mutant to BLT-1 | Proc Natl Acad Sci U S A. 2011 Jul 26;108(30):12243-8. |
LdlA[SR-BI] cells | 1 µM | 1 hour | Evaluate the inhibitory effect of BLT-1 on SR-BI-mediated DiI-HDL lipid uptake, showing that BLT-1 inhibition of SR-BI is essentially irreversible | Proc Natl Acad Sci U S A. 2011 Jul 26;108(30):12243-8. |
Human monocyte-derived macrophages (HMDMs) | 10 µM | 1 hour | BLT-1 treatment increased miR-223-3p export to HDL in HMDMs | Atherosclerosis. 2019 Jul;286:20-29. |
Polymorphonuclear neutrophils (PMNs) | 10 µM | 1 hour | Chemical inhibition of cholesterol flux by BLT-1 inhibited HDL-induced pri-mir-223 expression in PMNs | Atherosclerosis. 2019 Jul;286:20-29. |
COS7 cells | 10 µM | 1 hour | BLT-1 inhibits SR-B1-mediated HDL-CE uptake but does not affect fatty acid uptake | Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Feb;1865(2):158554. |
HEK293 cells | 10 µM | 1 hour | BLT-1 inhibits SR-B1-mediated HDL-CE uptake but does not affect fatty acid uptake | Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Feb;1865(2):158554. |
J774 macrophages | 1 µM | 2 hours | To block SR-BI mediated cholesterol efflux | Arterioscler Thromb Vasc Biol. 2010 Apr;30(4):796-801. |
Caco-2 cells | 10 µM | 2 hours | To investigate the effect of BLT-1 on vitamin K uptake, results showed that BLT-1 significantly reduced the uptake of vitamin K. | Mol Pharm. 2018 Sep 4;15(9):3786-3795. |
P. falciparum (3D7 line) | 500 μg/ml | 24 hours | To study HDL uptake and its competitive inhibition, HDL uptake was competitively inhibited by unlabeled HDL | Front Cell Dev Biol. 2021 Nov 11;9:749153. |
B cell lymphoma cell lines (DAUDI, BALL1, TL-1, RAJI, SLVL) | 10 µM | 24 hours | Inhibited lymphoma cell proliferation | Cancer Sci. 2022 Jun;113(6):2129-2143. |
ATLL cell lines (ATN-1, ED, ATL-T, ATL-2s, ATL-35T, MT-1) | 10 µM | 24 hours | Inhibited lymphoma cell proliferation and induced apoptosis | Cancer Sci. 2022 Jun;113(6):2129-2143. |
HCMEC/D3 cells | 1 µM | 4 hours | To evaluate the effect of BLT-1 on HDL-mediated protection of BBB integrity, showing that 1 µM BLT-1 partially counteracted the protective effects of HDLs | Int J Mol Sci. 2020 Dec 24;22(1):106. |
Primary bovine umbilical vein endothelial cells (BUVEC) | 2 µM | 48 hours | To study the effect of BLT-1 on the proliferation of E. bovis and E. arloingi, results showed that BLT-1 significantly inhibited the replication of these parasites. | Microorganisms. 2021 Nov 17;9(11):2372. |
African green monkey kidney epithelial cells (MARC 145) | 0.25-2 µM | 48 hours | To study the effect of BLT-1 on the proliferation of T. gondii, N. caninum, and B. besnoiti, results showed that BLT-1 significantly inhibited the replication of these parasites. | Microorganisms. 2021 Nov 17;9(11):2372. |
Administration | Dosage | Frequency | Description | References | ||
SCID mice | Subcutaneous ED cell lymphoma model | Intraperitoneal injection | 20 mg/kg | Administered daily from day 14 to day 32 | Significantly suppressed tumor development and prolonged survival | Cancer Sci. 2022 Jun;113(6):2129-2143. |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
4.14mL 0.83mL 0.41mL |
20.71mL 4.14mL 2.07mL |
41.43mL 8.29mL 4.14mL |
CAS号 | 321673-30-7 |
分子式 | C12H23N3S |
分子量 | 241.4 |
SMILES Code | S=C(N)N/N=C1C(CCCCCC)CCC\1 |
MDL No. | MFCD00571007 |
别名 | Block lipid transport-1 |
运输 | 蓝冰 |
存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, sealed in dry, 2-8°C |
溶解方案 |
DMSO: 40 mg/mL(165.7 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|